Get started
Author

Anna Lemska

Observed name: Lemska, Anna
ORCID: 0000-0003-0519-9007
Observed ORCID: 0000-0003-0519-9007
OpenAlex ID: A5037850138
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial
2021 · Eugenio Mercuri, Nicolas Deconinck, et al. · The Lancet Neurology · 253
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial
2022 · Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, et al. · The Lancet Neurology · 128
PDF
Nusinersen treatment of Spinal Muscular Atrophy Type 1 — results of expanded access programme in Poland
2021 · Sandra Modrzejewska, Katarzyna Kotulska, et al. · Neurologia i Neurochirurgia Polska · 29
PDF
The PURPLE N study: objective and perceived nutritional status in children and adolescents with cerebral palsy
2021 · Andras Fogarasi, Elisa Fazzi, et al. · Disability and Rehabilitation · 18
Next-generation sequencing testing in children with epilepsy reveals novel clinical, diagnostic and therapeutic implications
2024 · Magdalena Krygier, Marta Pietruszka, et al. · Frontiers in Genetics · 11
PDF
Efficacy of Nusinersen Treatment in Type 1, 2, and 3 Spinal Muscular Atrophy: Real-World Data from a Single-Center Study
2024 · Anna Lemska, Piotr Ruminski, et al. · Neurology International · 9
PDF
Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial
2026 · Maria Mazurkiewicz-Bełdzińska, Laurent Servais, et al. · The Lancet Child & Adolescent Health · 3
Development of a chromatographic method for the analysis of risdiplam in serum extracts
2026 · Natalia Balińska, Anna Lemska, et al. · Bioanalysis · 2
Peri-ictal headaches in the paediatric population – prospective study
2020 · Marta Zawadzka, Ewa Pilarska, et al. · Cephalalgia · 2
Therapeutic oligonucleotide (nusinersen) metabolism in cerebrospinal fluid samples of patients with spinal muscular atrophy based on liquid chromatography coupled with mass spectrometry data
2026 · Sylwia Studzińska, Anna Lemska, et al. · Analytica Chimica Acta · 1
1.71eP Clinical characteristics and treatment outcomes in patients with spinal muscular atrophy and four SMN2 copies
2026 · Anna Lemska, Sylwia Studzińska, et al. · Neuromuscular Disorders
1.88P Real-world effectiveness of risdiplam in spinal muscular atrophy: a single-center experience compared with pivotal trials
2026 · Anna Lemska, Sylwia Studzinska, et al. · Neuromuscular Disorders
Elevated serum IL-18 and IL-37 levels and their association with seizure burden in paediatric epilepsy
2026 · Marta Zawadzka, Jolanta Gleń, et al. · Frontiers in Immunology
PDF
A study on the quality of life and burden of informal caregivers of children with metachromatic leukodystrophy in Poland
2026 · Dariusz Walkowiak, Tomasz Grybek, et al. · Orphanet Journal of Rare Diseases
New sorbents for the selective extraction of risdiplam and its metabolite from the human serum
2026 · Studzińska, Sylwia, Natalia Balińska, et al. · RepOD
The silica-based sorbents for the mixed-mode extraction of risdiplam and its metabolite from serum samples
2026 · Natalia Balińska, Anna Lemska, et al. · Journal of Chromatography A
PDF
Risdiplam as Effective Bridge Therapy Before Gene Replacement in Presymptomatic Infants with SMA (P9-8.006)
2026 · Maria Mazurkiewicz-Beldzinska, Anna Lemska · Neurology
Prominent Movement Disorders in RNU2 ‐2‐Related Spliceosomopathy
2026 · Magdalena Krygier, Ugo Sorrentino, et al. · Annals of Clinical and Translational Neurology
Metabolic Complications and Ultrasound‐Detected Liver Abnormalities in Paediatric Patients With Duchenne Muscular Dystrophy
2026 · Karolina Śledzińska, Kornelia Polat, et al. · Pediatric Obesity
Development of a chromatographic method for the analysis of risdiplam in serum extracts
2026 · Balińska, Natalia, Lemska, Anna, et al. · Figshare
Silica-based sorbents for the mixed-mode extraction of risdiplam and its metabolite from serum samples
2026 · Studzińska, Sylwia, Lemska, Anna, et al. · RepOD
Clinical and EEG predictors of treatment response in pediatric absence epilepsy — a single-center experience
2025 · Anna Lemska, Marta Zawadzka, et al. · Neurologia i Neurochirurgia Polska
PDF
Vamorolone as an alternative to standard steroid therapy in the treatment of Duchenne muscular dystrophy – analysis of efficacy and safety
2025 · Anna Lemska, Maria Mazurkiewicz-Bełdzińska · Child Neurology
PDF
Efficacy of nusinersen treatment in type 1, 2, and 3 spinal muscular atrophy: real-world data from a single-center study
2024 · Anna Lemska, Piotr Ruminski, et al. · Child Neurology
PDF
Diagnostyka prenatalna i postnatalna rdzeniowego zaniku mięśni — opis przypadku i przegląd możliwości terapeutycznych
2024 · Piotr Rumiński, Anna Lemska, et al. · Child Neurology
PDF
Works count: 29
Citation count: 456
H-index: 6
I10-index: 5
Year
Topic
Type